NR 606 MIDTERM AND FINAL
EXAM COMPILATION ACTUAL
EXAM 2026/2027 - 100% VERIFIED
LATEST MOCK PRACTICE SET
178 Questions with Answers and Detailed Rationales
100 PERCENT GUARANTEED PASS
INSTANT DOWNLOAD ANSWERS INCLUDED
IMPORTANCE OF THIS DOCUMENT
This comprehensive examination preparation guide has been meticulously developed to help you succeed in the
NR 606 MIDTERM AND FINAL EXAM COMPILATION ACTUAL EXAM 2026/2027 - 100% VERIFIED | DETAILED
RATIONALES - PASS GUARANTEED - A+ GRADED. It contains 178 carefully selected questions that reflect the
most current exam content and testing strategies. Each question is accompanied by a correct answer and a
detailed rationale that explains the underlying pathophysiology, pharmacology, or clinical reasoning.
Self-Assessment – Test your knowledge and Exam Preparation – Familiarize yourself with the
identify areas requiring further question format and content
study areas
Concept Reinforcement – Deepen your Confidence Building – Develop test-taking
understanding through strategies and reduce
evidence-based exam anxiety
rationales
Time Management – Practice answering
questions under simulated
exam conditions
Review Summary 178 Questions
Foundations - Application - NR 606 AND Compilation Actual 2026/2027 100 Detailed Rationales PASS
Guaranteed A Psychiatric Mental Health Nurse Practitioner Pmhnp Graduate
All answers with rationales
,Table of Contents
Section A - Disorder Section B - Appropriate
Questions 1 to 45 Questions 46 to 90
Section C - Medication Section D - Mechanism
Questions 91 to 135 Questions 136 to 178
,Section A - Disorder
Q1.
A patient with bipolar I disorder, currently euthymic on lithium, develops new-onset
tremor and polyuria. Labs show lithium level 1.2 mEq/L, serum creatinine 1.4 mg/dL
(baseline 0.9), and urine osmolality 250 mOsm/kg. Which intervention is most
appropriate?
A. Continue lithium, add propranolol for B. Reduce lithium dose and monitor renal
tremor. function closely.
C. Switch to valproic acid immediately. D. Add desmopressin to manage diabetes
insipidus.
Correct: B - Reduce lithium dose and monitor renal function closely.
Rationale:The patient exhibits lithium toxicity (level >1.0 mEq/L) and nephrogenic diabetes
insipidus (polyuria, dilute urine). Reducing dose addresses both toxicity and renal effects.
Propranolol treats tremor but not toxicity; switching to valproic acid may be premature without
dose adjustment; desmopressin is contraindicated in nephrogenic DI.
Q2.
In a patient with treatment-resistant major depressive disorder, which combination
strategy is most supported by current evidence for augmentation?
A. Buspirone added to SSRIs B. Atypical antipsychotic (e.g., aripiprazole)
added to SSRI/SNRI
C. Lithium added to MAOI D. T3 (liothyronine) added to TCA
Correct: B - Atypical antipsychotic (e.g., aripiprazole) added to SSRI/SNRI
Rationale:Atypical antipsychotics have robust FDA indications for adjunctive treatment of
MDD. Lithium and T3 have evidence but are not first-line augmenting agents in current
guidelines; buspirone has weaker evidence.
Q3.
Which pharmacogenetic variant is associated with increased risk of serotonin syndrome
when a patient is prescribed a CYP2D6 substrate SSRI?
A. CYP2D6 ultrarapid metabolizer B. CYP2D6 poor metabolizer
C. CYP3A4 inducer D. CYP1A2 inhibitor
Correct: B - CYP2D6 poor metabolizer
Page 3
, Section A - Disorder
Rationale: Poor metabolizers have reduced enzyme activity, leading to higher drug
concentrations and increased serotonergic effects, raising serotonin syndrome risk. Ultrarapid
metabolizers clear the drug faster, lowering risk.
Q4.
A patient on long-term clozapine presents with fever, sore throat, and malaise. Labs show
absolute neutrophil count 800/µL. What is the immediate priority?
A. Continue clozapine and monitor CBC B. Discontinue clozapine and refer for
daily. hematologic evaluation.
C. Reduce clozapine dose and add D. Switch to olanzapine and reassure the
filgrastim. patient.
Correct: B - Discontinue clozapine and refer for hematologic evaluation.
Rationale:ANC <1000/µL indicates severe neutropenia, requiring immediate clozapine
discontinuation and hematology consult. Continuing or reducing dose is unsafe; filgrastim
may be used but not without discontinuation; switching without workup is inappropriate.
Q5.
Which statement accurately reflects the mechanism of action of brexanolone in
postpartum depression?
A. Selective serotonin reuptake inhibition B. Positive allosteric modulation of GABA-A
receptors
C. NMDA receptor antagonism D. Monoamine oxidase inhibition
Correct: B - Positive allosteric modulation of GABA-A receptors
Rationale:Brexanolone is a neuroactive steroid that acts as a positive allosteric modulator at
GABA-A receptors, enhancing inhibitory neurotransmission. It does not primarily affect
serotonin, NMDA, or MAO pathways.
Q6.
A patient with schizophrenia is adherent to long-acting injectable paliperidone but
continues to experience persistent negative symptoms. Which adjunctive intervention has
the strongest evidence base?
A. Add a second antipsychotic B. Cognitive behavioral therapy for
psychosis
C. High-dose benzodiazepines D. Routine use of anticholinergics
Correct: B - Cognitive behavioral therapy for psychosis
Page 4
EXAM COMPILATION ACTUAL
EXAM 2026/2027 - 100% VERIFIED
LATEST MOCK PRACTICE SET
178 Questions with Answers and Detailed Rationales
100 PERCENT GUARANTEED PASS
INSTANT DOWNLOAD ANSWERS INCLUDED
IMPORTANCE OF THIS DOCUMENT
This comprehensive examination preparation guide has been meticulously developed to help you succeed in the
NR 606 MIDTERM AND FINAL EXAM COMPILATION ACTUAL EXAM 2026/2027 - 100% VERIFIED | DETAILED
RATIONALES - PASS GUARANTEED - A+ GRADED. It contains 178 carefully selected questions that reflect the
most current exam content and testing strategies. Each question is accompanied by a correct answer and a
detailed rationale that explains the underlying pathophysiology, pharmacology, or clinical reasoning.
Self-Assessment – Test your knowledge and Exam Preparation – Familiarize yourself with the
identify areas requiring further question format and content
study areas
Concept Reinforcement – Deepen your Confidence Building – Develop test-taking
understanding through strategies and reduce
evidence-based exam anxiety
rationales
Time Management – Practice answering
questions under simulated
exam conditions
Review Summary 178 Questions
Foundations - Application - NR 606 AND Compilation Actual 2026/2027 100 Detailed Rationales PASS
Guaranteed A Psychiatric Mental Health Nurse Practitioner Pmhnp Graduate
All answers with rationales
,Table of Contents
Section A - Disorder Section B - Appropriate
Questions 1 to 45 Questions 46 to 90
Section C - Medication Section D - Mechanism
Questions 91 to 135 Questions 136 to 178
,Section A - Disorder
Q1.
A patient with bipolar I disorder, currently euthymic on lithium, develops new-onset
tremor and polyuria. Labs show lithium level 1.2 mEq/L, serum creatinine 1.4 mg/dL
(baseline 0.9), and urine osmolality 250 mOsm/kg. Which intervention is most
appropriate?
A. Continue lithium, add propranolol for B. Reduce lithium dose and monitor renal
tremor. function closely.
C. Switch to valproic acid immediately. D. Add desmopressin to manage diabetes
insipidus.
Correct: B - Reduce lithium dose and monitor renal function closely.
Rationale:The patient exhibits lithium toxicity (level >1.0 mEq/L) and nephrogenic diabetes
insipidus (polyuria, dilute urine). Reducing dose addresses both toxicity and renal effects.
Propranolol treats tremor but not toxicity; switching to valproic acid may be premature without
dose adjustment; desmopressin is contraindicated in nephrogenic DI.
Q2.
In a patient with treatment-resistant major depressive disorder, which combination
strategy is most supported by current evidence for augmentation?
A. Buspirone added to SSRIs B. Atypical antipsychotic (e.g., aripiprazole)
added to SSRI/SNRI
C. Lithium added to MAOI D. T3 (liothyronine) added to TCA
Correct: B - Atypical antipsychotic (e.g., aripiprazole) added to SSRI/SNRI
Rationale:Atypical antipsychotics have robust FDA indications for adjunctive treatment of
MDD. Lithium and T3 have evidence but are not first-line augmenting agents in current
guidelines; buspirone has weaker evidence.
Q3.
Which pharmacogenetic variant is associated with increased risk of serotonin syndrome
when a patient is prescribed a CYP2D6 substrate SSRI?
A. CYP2D6 ultrarapid metabolizer B. CYP2D6 poor metabolizer
C. CYP3A4 inducer D. CYP1A2 inhibitor
Correct: B - CYP2D6 poor metabolizer
Page 3
, Section A - Disorder
Rationale: Poor metabolizers have reduced enzyme activity, leading to higher drug
concentrations and increased serotonergic effects, raising serotonin syndrome risk. Ultrarapid
metabolizers clear the drug faster, lowering risk.
Q4.
A patient on long-term clozapine presents with fever, sore throat, and malaise. Labs show
absolute neutrophil count 800/µL. What is the immediate priority?
A. Continue clozapine and monitor CBC B. Discontinue clozapine and refer for
daily. hematologic evaluation.
C. Reduce clozapine dose and add D. Switch to olanzapine and reassure the
filgrastim. patient.
Correct: B - Discontinue clozapine and refer for hematologic evaluation.
Rationale:ANC <1000/µL indicates severe neutropenia, requiring immediate clozapine
discontinuation and hematology consult. Continuing or reducing dose is unsafe; filgrastim
may be used but not without discontinuation; switching without workup is inappropriate.
Q5.
Which statement accurately reflects the mechanism of action of brexanolone in
postpartum depression?
A. Selective serotonin reuptake inhibition B. Positive allosteric modulation of GABA-A
receptors
C. NMDA receptor antagonism D. Monoamine oxidase inhibition
Correct: B - Positive allosteric modulation of GABA-A receptors
Rationale:Brexanolone is a neuroactive steroid that acts as a positive allosteric modulator at
GABA-A receptors, enhancing inhibitory neurotransmission. It does not primarily affect
serotonin, NMDA, or MAO pathways.
Q6.
A patient with schizophrenia is adherent to long-acting injectable paliperidone but
continues to experience persistent negative symptoms. Which adjunctive intervention has
the strongest evidence base?
A. Add a second antipsychotic B. Cognitive behavioral therapy for
psychosis
C. High-dose benzodiazepines D. Routine use of anticholinergics
Correct: B - Cognitive behavioral therapy for psychosis
Page 4
